Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: a Gynecologic Oncology Group Study

Gynecologic Oncology
J T ThigpenG C Lewis

Abstract

Thirty-eight patients with advanced or recurrent squamous cell carcinoma of the vulva no longer amenable to control with surgery and/or radiotherapy were entered onto one of two phase II studies. One was deemed ineligible because of a primary site of origin other than vulva. Of the remaining 37, 13 patients received piperazinedione 9 mg/m2 iv every 3 weeks. No objective regressions were observed. Five patients were judged to have had stable disease, while eight demonstrated increasing disease. The other 24 patients received cisplatin 50 mg/m2 iv every 3 weeks. Of the 22 who were evaluable for response because of the presence of measurable disease, no objective regression of disease was observed. Ten had stable disease, while the remaining 12 had increasing disease. Adverse effects were tolerable for each study agent and were essentially those reported in other series for these two drugs. These results suggest that neither agent is active in advanced or recurrent squamous cell carcinoma of the vulva at least at the dose and schedule tested.

Citations

Dec 21, 2000·Current Oncology Reports·J D Bloss
Jun 25, 2003·Gynecologic Oncology·Manish AgrawalHerb Kotz
Feb 3, 2000·International Journal of Radiation Oncology, Biology, Physics·S PingleyK A Dinshaw
Sep 26, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K Y LookUNKNOWN Gynecologic Oncology Group Study
Mar 23, 2013·Wiener klinische Wochenschrift·Gunter DeppeIra S Winer
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Misa RaitanenSeija Grénman
May 24, 2011·Critical Reviews in Oncology/hematology·Federica TomaoPierluigi Benedetti Panici
Sep 2, 2006·Critical Reviews in Oncology/hematology·Angiolo GadducciAndrea Riccardo Genazzani
Jul 4, 2012·Gynecologic Oncology·N S HorowitzD S Dizon
Oct 15, 1987·Cancer·T ThigpenR McGehee
Nov 22, 2017·International Journal of Clinical Oncology·Toshiaki SaitoHidetaka Katabuchi
May 25, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harry J LongUNKNOWN Gynecologic Oncology Group Study
Dec 12, 2019·Archives of Gynecology and Obstetrics·Anna JaegerLinn Woelber
Jan 1, 2010·Oncology Letters·Angiolo GadducciLuca Cionini
Jul 24, 2014·Molecular and Clinical Oncology·Miho IidaDaisuke Aoki
May 23, 2015·Expert Review of Anticancer Therapy·Sven MahnerLinn Woelber
Aug 28, 2021·Cancers·Marco MazzottaPatrizia Vici

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.